-
Mashup Score: 0
Dr. Balazs Halmos discusses the significance of the approval of subcutaneous Opdivo and what this treatment formulation means for those with solid tumors.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0
The Food and Drug Administration has accepted and granted priority review to a new drug application for sunvozertinib.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
FDA Grants Priority Review to Sunvozertinib for EGFR Exon20+ NSCLC. #NSCLC #EGFR @Dizal_Global https://t.co/V3bo9pj338
-
-
Mashup Score: 0
Treatment with fixed-dose subcutaneous Sarclisa plus Pomalyst and dexamethasone was non-inferior to IV Sarclisa in relapsed/refractory multiple myeloma.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Fixed-Dose Subcutaneous Sarclisa Combo is Non-Inferior to IV Sarclisa in R/R #Myeloma @MayoClinic #mmsm #oncology https://t.co/5JB5WwfvjJ
-
-
Mashup Score: 0Finding Strength Through Faith and Positivity During Cancer - 4 day(s) ago
I share how faith, positive affirmations and resilience helped me overcome stage 2 colon cancer and find strength in recovery.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Finding Strength Through Faith and Positivity During Cancer #CancerJourney #ColonCancer https://t.co/eDeZTd4Vc5
-
-
Mashup Score: 0
Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Long-Term Patient Care Focuses on Precision-Based Therapy in Breast Cancer @BIDMChealth @SABCSSanAntonio #SABCS24 #Oncology #bcsm https://t.co/9zZYUzdPVK
-
-
Mashup Score: 0
The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Sasanlimab Improves Event-Free Survival for Some With #BladderCancer. @pfizer https://t.co/93xEvQTOhv
-
-
Mashup Score: 0SBRT May Be a Viable Option for Patients With Liver Cancer - 4 day(s) ago
CURE spoke with an expert about the potential positive effects of radiation therapy for patients with hepatocellular carcinoma.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
SBRT May Be a Viable Option for Patients With #LiverCancer @ldawsonmd @pmcancercentre #MedTwitter #Oncology https://t.co/bKE3tiVkLg
-
-
Mashup Score: 0
The FDA has approved Lumakras with Vectibix for adults with KRAS G12C-mutated metastatic colorectal cancer who received chemotherapy.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
The @US_FDA Approves Lumakras with Vectibix in KRAS G12C+ Colorectal Cancer #FDAApproved #Oncology https://t.co/7SyMzRSJK6
-
-
Mashup Score: 4
Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
HIPEC May Not Improve Outcomes for Recurrent Epithelial Ovarian Cancer @JCO_ASCO #gyncsm #oncology https://t.co/C6JdvEzt0M
-
-
Mashup Score: 0
P1101 had durable hematologic responses and manageable safety among patients with essential thrombocythemia, meeting the primary end goal of SURPASS-ET.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
P1101 Treatment Meets Phase 3 Primary End Point in Essential #Thrombocythemia. @PharmaEssentia https://t.co/F95XKlSOWz
-
The Significance of the Subcutaneous Opdivo FDA Approval in Solid Tumors @BalazsHalmosMD @EinsteinMed @US_fda #Oncology #MedTwitter https://t.co/JahkVywwH4